ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases

Br J Cancer. 2003 Jul 21;89(2):246-7. doi: 10.1038/sj.bjc.6601116.

Abstract

The activity of ZD 1839 on brain metastases (BM) from Non-Small-Cell Lung Cancer (NSCLC) is unknown. We report four cases of BM responding to ZD 1839 theraphy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / pharmacology*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / radiotherapy
  • Brain Neoplasms / secondary*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / radiotherapy
  • Carcinoma, Non-Small-Cell Lung / secondary*
  • Female
  • Gefitinib
  • Humans
  • Lung Neoplasms / pathology*
  • Male
  • Middle Aged
  • Quinazolines / pharmacology*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Gefitinib